GEGR.US National Health Scan
- Market cap
- USD 174K
- P/E
- -
- P/B
- -
- ROE
- -0.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2024.
Is GEGR.US undervalued?
Graham numberThe Graham number of National Health Scan cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
National Health Scan fundamental analysis
No fundamental analysis for National Health Scan yet.
National Health Scan stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About National Health Scan
Gaensel Energy Group, Inc. operates as a medical or healthcare industry business incubator. The company operates multi-channel Internet-only radio network. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. Gaensel Energy Group, Inc. was formerly known as National Health Scan, Inc. and changed its name to Gaensel Energy Group, Inc. in February 2015. Gaensel E…
Full company profileNational Health Scan financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
National Health Scan annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 77.9M | 93.7M | 25.9M | - |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 49.5M | 53.4M | 22.7M | - |
| Operating Income | -16.7K | -174K | -721K | -661K | - | - | - | 36.1M | 29.7M | 13.8M | -71.4K |
| EBITDA | -11.0K | -181K | -680K | -661K | - | - | - | 36.1M | 29.9M | 13.9M | -71.4K |
| Net Income | -11.0K | -181K | -680K | -661K | - | - | - | 36.1M | 29.7M | 13.8M | -71.4K |
| EPS | 0.00 | 0.00 | -0.01 | 0.00 | - | - | - | 0.11 | 0.12 | 0.06 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | - | 1.64K | 693.00 | 455.00 | - | - | 463K | 56.1M | 34.2M | 12.0M | 12.0M |
| Total Liabilities | 36.2K | 218K | 318K | 463K | 463K | 463K | 463K | 33.4M | 21.1M | 613K | 631K |
| Shareholders' Equity | - | -217K | -317K | -463K | -463K | -463K | 146K | 22.7M | 13.1M | 11.4M | 11.4M |
| Cash & Short-term Investments | - | 1.64K | 693.00 | 455.00 | - | - | - | 11.5M | 2.52M | - | - |
| Total Debt | - | - | - | - | 463K | 463K | 463K | 24.3M | 15.4M | 613K | 631K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -16.0K | -16.0K | -17.8K | -19.2K | -455.00 | - | - | 23.1M | 39.3M | 12.7M | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 3.00 | 1.00 | - |
| Free Cash Flow | - | -16.0K | -17.8K | -19.2K | -455.00 | - | - | 23.1M | 39.3M | 12.7M | - |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | - | - | 159.2% | 226.9% | 120.8% | -0.6% |
| ROA | - | -11,029.9% | -98,124.1% | -145,274.7% | - | - | - | 64.4% | 86.7% | 114.6% | -0.6% |
| Net Profit Margin | - | - | - | - | - | - | - | 46.4% | 31.7% | 53.1% | - |
| Debt to Equity | - | - | - | - | - | - | 3.17x | 1.07x | 1.18x | 0.05x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
National Health Scan dividends
National Health Scan has not paid dividends in the last 8 fiscal years.
Last stock split: 1:100 on Feb 9, 2006.
Who owns National Health Scan
Ownership data of National Health Scan is not available yet.
National Health Scan company profile
- Company name
- National Health Scan
- Ticker
- GEGR.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Fiscal year end
- December
- Address
- 2034 Cotner, Los Angeles, CA, United States, 90025
- Phone
- 310-914-4587
- Website
- gegrgroup.com
About National Health Scan
Gaensel Energy Group, Inc. operates as a medical or healthcare industry business incubator. The company operates multi-channel Internet-only radio network. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. Gaensel Energy Group, Inc. was formerly known as National Health Scan, Inc. and changed its name to Gaensel Energy Group, Inc. in February 2015. Gaensel Energy Group, Inc. was founded in 1994 and is based in Los Angeles, California.
National Health Scan management
2- Mr. Peter Albert KoleyChief Executive Officer · born 1965
- Mr. Jose SalazarCorporate Secretary & Director